NCT06925906View on ClinicalTrials.gov

Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

June 6, 2024

Study Completion Date

August 18, 2024

Conditions
Abdominal Cancer
Trial Locations (1)

K1H 8L6

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER

NCT06925906 - Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen | Biotech Hunter | Biotech Hunter